Texas Medical Technology Inc

Form 483 issued March 3, 2022 · Houston, Texas

Inspection
Feb 16 – Mar 3, 2022
Investigator
Ellen J. Tave
Observations
9
Pages
10
FEI number
3016808907

In short: On March 3, 2022, FDA issued a Form 483 with 9 observations to Texas Medical Technology Inc in Houston, Texas (FEI 3016808907) after an inspection that ran Feb 16 – Mar 3, 2022. The investigator was Ellen J. Tave. Most observations concern production & process controls and records & documents.

At a glance

Production & process controls and records & documents account for 7 of 9 observations.

Production & process controls5
Records & documents2
CAPA2

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures to ensure that all purchased or otherwise received product and services conform to specified requirements…

  2. 02

    A process whose results cannot be fully verified by subsequent inspection and test has not been…

  3. 03

    A device master record has…

  4. 04

    Procedmes for device history records have…

5 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Texas Medical Technology Inc?

FDA listed 9 observations on this Form 483, mostly about production & process controls, records & documents and cAPA. The opening words of each observation are shown on this page.

Who inspected Texas Medical Technology Inc?

Ellen J. Tave is named on this Form 483, for the inspection of Feb 16 – Mar 3, 2022. Each investigator has a profile showing what they cite most.

When was Texas Medical Technology Inc inspected by FDA?

The inspection ran Feb 16 – Mar 3, 2022, and the Form 483 is dated March 3, 2022.

How do I get the full Form 483 for Texas Medical Technology Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free